Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Veeva Systems (VEEV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Veeva Systems — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while Veeva Systems trades at $290.83 (market cap $46.12B). The key difference: Veeva Systems is far larger — about 7.6× Iovance Biotherapeutics Inc. Common Stock's market cap, and Veeva Systems is more actively traded (921,537 versus 14,805,993). Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Veeva Systems for 5 Days on average.
| IOVA | VEEV | |
|---|---|---|
Market Cap | $6.04B | $46.12B |
Volume | 14,805,993 | 921,537 |
Sector | Health | Technology |
52-Week High | $14.82 | $299.10 |
52-Week Low | $1.81 | $151.43 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $5.97B | $39.03B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Veeva Systems
Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →
